Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119131

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

E Stroes, J Kastelein, F Cosentino, W Erkelens, R Wever, H Koomans, T Lüscher, and T Rabelink

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Stroes, E. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Kastelein, J. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Cosentino, F. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Erkelens, W. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Wever, R. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Koomans, H. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Lüscher, T. in: JCI | PubMed | Google Scholar

Department of Nephrology, University Hospital Utrecht, The Netherlands.

Find articles by Rabelink, T. in: JCI | PubMed | Google Scholar

Published January 1, 1997 - More info

Published in Volume 99, Issue 1 on January 1, 1997
J Clin Invest. 1997;99(1):41–46. https://doi.org/10.1172/JCI119131.
© 1997 The American Society for Clinical Investigation
Published January 1, 1997 - Version history
View PDF
Abstract

In hypercholesterolemia, impaired nitric oxide activity has been associated with increased nitric oxide degradation by oxygen radicals. Deficiency of tetrahydrobiopterin, an essential cofactor of nitric oxide synthase, causes both impaired nitric oxide activity and increased oxygen radical formation. In this study we tested whether tetrahydrobiopterin deficiency contributes to the decreased nitric oxide activity observed in hypercholesterolemic patients. Therefore, L-mono-methyl-arginine to inhibit basal nitric oxide activity, serotonin to stimulate nitric oxide activity, and nitroprusside as endothelium-independent vasodilator were infused in the brachial artery of 13 patients with familial hypercholesterolemia and 13 matched controls. The infusions were repeated during coinfusion of L-arginine (200 microg/kg/min), tetrahydrobiopterin (500 microg/min), or the combination of both compounds. Forearm vasomotion was assessed using forearm venous occlusion plethysmography and expressed as ratio of blood flow between measurement and control arm (M/C ratio). Tetrahydrobiopterin infusion alone did not alter M/C ratio. Both the attenuated L-mono-methyl-arginine-induced vasoconstriction as well as the impaired serotonin-induced vasodilation were restored in patients during tetrahydrobiopterin infusion. Tetrahydrobiopterin had no effect in controls. In conclusion, this study demonstrates restoration of endothelial dysfunction by tetrahydrobiopterin suppletion in hypercholesterolemic patients.

Version history
  • Version 1 (January 1, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts